Revolutionizing Healthcare with Whole Genome Sequencing and AI

So it's a little bit different because we do all of it. We do whole genome sequencing, we have the GI effects. We're the only company doing both genotypic and phenotypic measurements, which has been really exciting for us to watch how these things intertwine because we're basically the only company doing it. So it's, again, we're still in our infancy to understand how this comes, but because we've been around a very long time, we sit on hundreds and hundreds of thousands of data points and we use artificial intelligence to create scores, to create algorithms, to Michael's point earlier, to see if we can predict inflammation, if you're setting yourself for inflammation in the future, we're looking at various different algorithms and perhaps even going across product lines to look at all of the data points for the GI effects as it relates then to the nutrival, as it relates to hormones, to see how all of this combines. Because now that we have this whole genome sequencing, we're looking towards the future to push the entire field forward.